menu
    • menu

    Company profile for ACCELRX LABS

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ACCELRX LABSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tetraphase Announces Second Amendment to Merger Agreement with AcelRx
    Tetraphase Announces Second Amendment to Merger Agreement with AcelRx

    29 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200529005335/en/Tetraphase-Announces-Amendment-Merger-Agreement-AcelRx-Pharmaceuticals

    BUSINESSWIRE
    29 May 2020
    Share Share
    AcelRx Pharmaceuticals Completes Pts. Enrollment in PIII Studies of ARX-04
    AcelRx Pharmaceuticals Completes Pts. Enrollment in PIII Studies of ARX-04

    28 Jun 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-completes-patient-enrollment-in-remaining-phase-3-studies-of-arx-04-as-a-potential-treatment-of-moderate-to-severe-acute-pain-300290366.html

    PR NEWSWIRE
    28 Jun 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search